Literature DB >> 23581285

Influence of seroreactivity to leptospira and reproductive failures in recipient mares of equine embryo transfer programmes.

A Pinna1, G Martins, G Souza, W Lilenbaum.   

Abstract

The aim of this study was to demonstrate that seroreactivity against Leptospira is significantly associated to the reproductive efficiency of recipient mares of an embryo transfer (ET) programme. A serosurvey was conducted from August 2007 to March 2009 in five herds from Rio de Janeiro, Brazil, with high rates of reproductive failure, as early embryonic death (>12%), abortion (>12%) and perinatal death. Detailed information about the losses was obtained from practitioner. A total of 338 recipient mares were tested by microscopic agglutination test, and 226 (66.9%) were seroreactive, mainly against serovars Bratislava and Copenhageni. Seroreactivity could be associated to reproductive failure (p < 0.001), and it was demonstrated that a seroreactive mare is 1.8 times more likely (relative risk - RR) to present reproductive failure than a seronegative one, particularly in relation to early embryonic death (p < 0.0001; RR 8.4) but also to abortions (p < 0.0001; RR 3.5), and to perinatal death (p < 0.05; RR 7.3). Therefore, seroreactivity to Leptospira is associated to reproductive failure in all phases of pregnancy in recipient mares, impairing equine ET programmes.
© 2013 Blackwell Verlag GmbH.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23581285     DOI: 10.1111/rda.12166

Source DB:  PubMed          Journal:  Reprod Domest Anim        ISSN: 0936-6768            Impact factor:   2.005


  2 in total

1.  Leptospirosis is strongly associated to estrus repetition on cattle.

Authors:  H A Libonati; G B Santos; G N Souza; F Z Brandão; W Lilenbaum
Journal:  Trop Anim Health Prod       Date:  2018-05-02       Impact factor: 1.559

2.  Bovine endometrial cells do not mount an inflammatory response to Leptospira.

Authors:  Paula C C Molinari; Jarlath E Nally; John J Bromfield
Journal:  Reprod Fertil       Date:  2021-07-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.